XML 19 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Preferred Stock
Treasury Stock
Additional paid-in capital
Retained Earnings (Accumulated deficit)
Accumulated other comprehensive income (loss)
Noncontrolling interest in subsidiary
Common Stock, beginning balance (in shares) at Dec. 31, 2021   133,844,000            
Preferred Stock, beginning balance (in shares) at Dec. 31, 2021     124,000          
Treasury Stock, beginning balance (in shares) at Dec. 31, 2021       0        
Balance at beginning of period at Dec. 31, 2021 $ 2,066,689 $ 13 $ 1 $ 0 $ 2,107,267 $ (43,021) $ (2,354) $ 4,783
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Equity-based compensation (in shares)   187,000            
Equity-based compensation 5,502       5,502      
Exercise of stock options (in shares)   184,000            
Exercise of stock options 723       723      
Payments for tax withholdings from restricted stock vesting (1,269)       (1,269)      
Common Stock issued in connection with employee stock purchase plan (in shares)   31,000            
Common Stock issued in connection with employee stock purchase plan 753       753      
Net income 42,230         41,750   480
Change in fair value of interest rate swaps, inclusive of reclassification adjustment 5,998           5,998  
Common Stock, ending balance (in shares) at Mar. 31, 2022   134,246,000            
Preferred Stock, ending balance (in shares) at Mar. 31, 2022     124,000          
Treasury Stock, ending balance (in shares) at Mar. 31, 2022       0        
Balance at end of period at Mar. 31, 2022 $ 2,120,626 $ 13 $ 1 $ 0 2,112,976 (1,271) 3,644 5,263
Common Stock, beginning balance (in shares) at Dec. 31, 2022 134,435,119 134,435,000            
Preferred Stock, beginning balance (in shares) at Dec. 31, 2022 124,060   124,000          
Treasury Stock, beginning balance (in shares) at Dec. 31, 2022 750,835     751,000        
Balance at beginning of period at Dec. 31, 2022 $ 2,157,758 $ 13 $ 1 $ (13,992) 2,130,148 26,295 8,693 6,600
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Equity-based compensation (in shares)   292,000            
Equity-based compensation 5,916       5,916      
Payments for tax withholdings from restricted stock vesting (1,883)       (1,883)      
Common Stock issued in connection with employee stock purchase plan (in shares)   53,000            
Common Stock issued in connection with employee stock purchase plan 1,021       1,021      
Shares purchased under share repurchase program (in shares)   632,000   631,953        
Shares purchased under share repurchase program (9,224)     $ (9,224)        
Net income 16,675         15,707   968
Change in fair value of interest rate swaps, inclusive of reclassification adjustment $ (2,805)           (2,805)  
Common Stock, ending balance (in shares) at Mar. 31, 2023 134,148,031 134,148,000            
Preferred Stock, ending balance (in shares) at Mar. 31, 2023 124,060   124,000          
Treasury Stock, ending balance (in shares) at Mar. 31, 2023 1,382,788     1,383,000        
Balance at end of period at Mar. 31, 2023 $ 2,167,458 $ 13 $ 1 $ (23,216) $ 2,135,202 $ 42,002 $ 5,888 $ 7,568